Literature DB >> 6690676

Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome.

G Zilleruelo, S L Hsia, M Freundlich, H M Gorman, J Strauss.   

Abstract

We investigated the severity and duration of hyperlipidemia in 59 nephrotic children during relapse and remission. Serum total cholesterol and triglyceride values were greater than or equal to 95th percentile for age and sex in all patients with minimal change nephrotic syndrome in relapse and in patients with non-MCNS and persistent proteinuria. Most of these patients also had a significant elevation of low- and very-low-density lipoproteins. A significant number of children with MCNS during prolonged remission had elevated serum concentrations of total cholesterol (46%), triglycerides (42%), LDL (29%), and VLDL (40%). Persistence and severity of lipid changes correlated well with duration of disease and frequency of relapses. Significantly decreased HDL and HDL/LDL were found in patients with non-MCNS and persistent proteinuria. Our results suggest that nephrotic children may have prolonged periods of hyperlipidemia even after clinical remission. In addition, some of these children with significantly decreased HDL/LDL may be at increased risk of developing premature atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690676     DOI: 10.1016/s0022-3476(84)80590-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

1.  Factors influencing cardiovascular risk following termination of glucocorticoid therapy for nephrotic syndrome.

Authors:  Akio Nakamura; Ryo Niimi; Kumiko Kurosaki; Yukishige Yanagawa
Journal:  Clin Exp Nephrol       Date:  2010-07-17       Impact factor: 2.801

2.  Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case-control study.

Authors:  Illaparambath Rahul; Sriram Krishnamurthy; Santhosh Satheesh; Niranjan Biswal; Zachariah Bobby; Subitha Lakshminarayanan
Journal:  Clin Exp Nephrol       Date:  2014-03-18       Impact factor: 2.801

3.  Recent advances in minimal change nephrotic syndrome.

Authors:  K P Mehta; U Ali
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

4.  Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.

Authors:  Lionel C Clement; Camille Macé; Carmen Avila-Casado; Jaap A Joles; Sander Kersten; Sumant S Chugh
Journal:  Nat Med       Date:  2013-12-08       Impact factor: 53.440

5.  Paraoxonase Activity and Lipid Profile in Paediatric Nephrotic Syndrome: A Cross-sectional Study.

Authors:  Vijayetha P Patil; Anuradha B Patil; Vidya S Patil; Deepti G Ingleshwar
Journal:  J Clin Diagn Res       Date:  2016-03-01

Review 6.  Hyperlipidemia in childhood nephrotic syndrome.

Authors:  M A Thabet; J R Salcedo; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

7.  Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome.

Authors:  Maria H Kniazewska; Anna K Obuchowicz; Tomasz Wielkoszyński; Joanna Zmudzińska-Kitczak; Katarzyna Urban; Marta Marek; Jolanta Witanowska; Karolina Sieroń-Stołtny
Journal:  Pediatr Nephrol       Date:  2008-10-30       Impact factor: 3.714

8.  Subclinical cardiovascular disease and its association with risk factors in children with steroid-resistant nephrotic syndrome.

Authors:  Cengiz Candan; Nur Canpolat; Selman Gökalp; Nurdan Yıldız; Pınar Turhan; Mehmet Taşdemir; Lale Sever; Salim Çalışkan
Journal:  Pediatr Nephrol       Date:  2013-09-15       Impact factor: 3.714

9.  Lipoprotein profiles at different stages of the nephrotic syndrome.

Authors:  U Querfeld; A Gnasso; W Haberbosch; J Augustin; K Schärer
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

10.  Increased plasma acylation-stimulating protein in pediatric proteinuric renal disease.

Authors:  Jin Hui Tang; Yu Wen; Fei Wu; Xiao Y Zhao; Mei X Zhang; Jie Mi; Katherine Cianflone
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.